Assessing the Quality of Existing Clinical Practice Guidelines for Chemotherapy Drug Extravasation by Appraisal of Guidelines for Research and Evaluation II

Masoud Bahrami, Tayebeh Karimi, Ghasem Yadegarfar, Ali Norouzi

Abstract


Background: Extravasation is a potentially hazardous event that may occur during chemotherapy. The aim of this study is to assess the quality of existing Clinical Practice Guidelines (CPGs) for chemotherapy drug extravasation by Appraisal of Guidelines for Research and Evaluation II (AGREE II).

Materials and Methods: Valid electronic databases and CPGs from 2007 to August 2018 were searched by keywords of CPGs, extravasation, chemotherapy, and cancer. CPGs were evaluated independently by five experts through AGREE II tool, and the consensus among evaluators was calculated by ICC (Intra‑class Correlation Coefficient).

Results: Five of the 111 CPGs matched the inclusion criteria. The methodological quality of CPGs in domains of “scope and purpose,” “stakeholder involvement,” “clarity of presentation,” and “applicability” were good, in the domain of “rigor of development,” was acceptable, and in “editorial independence” domain, it needed more attention of developers of CPGs. The range of assessors’ consensus was within a range of moderate to very good (0.55‑‑0.93).

Conclusions: The methodological quality of existing CPGs of chemotherapy drugs extravasation assessed by AGREE II tool is appropriate. Four CPGs had high level while one had moderate level of quality. Therefore, their use is recommended in the clinic to reduce the risk of chemotherapy extravasation to the entire treatment team and the nurses working in the oncology departments.



Keywords


Appraisal of guidelines for research and evaluation II, drug therapy, extravasation of diagnostic and therapeutic materials, neoplasms, practice guideline

Full Text:

PDF

References


Pérez Fidalgo J, García Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F; ESMO Guidelines Working Group. Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines. Annals of oncology 2012;23(Suppl 7):vii167 vii73.

Mrayyan MT, Naga BS. Chemotherapy spill management policy: Policy analysis. Middle East J Nurs 2013;101:1 13.

O’grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter related infections. Clin Infect Dis 2011;52:e162 e93.

Cicolini G, Simonetti V, Comparcini D, Labeau S, Blot S, Pelusi G, et al. Nurses’ knowledge of evidence-based guidelines on the prevention of peripheral venous catheter-related infections: A multicentre survey. J Clin Nurs 2014;23:2578 88.

Azais H, Bresson L, Bassil A, Katdare N, Merlot B, Houpeau JL, et al. Chemotherapy drug extravasation in totally implantable venous access port systems: How effective is early surgical lavage? J Vasc Access 2015;16:31 7.

Sardanelli F, Bashir H, Berzaczy D, Cannella G, Espeland A, Flor N, et al. The role of imaging specialists as authors of systematic reviews on diagnostic and interventional imaging and its impact on scientific quality: Report from the EuroAIM Evidence based Radiology Working Group. Radiology 2014;272:533 40.

Alonso Coello P, Irfan A, Solà I, Gich I, Delgado Noguera M, Rigau D, et al. The quality of clinical practice guidelines over the last two decades: A systematic review of guideline appraisal studies. Qual Saf Health Care 2010;19:e58.

Dans AL, Dans LF. Appraising a tool for guideline appraisal (the AGREE II instrument). J Clin Epidemiol 2010;63:1281 2.

Burgers JS, Fervers B, Haugh M, Brouwers M, Browman G, Philip T, et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 2004;22:2000 7.

Melnyk BM, Fineout Overholt E. Evidence Based Practice in Nursing & Healthcare: A Guide to Best Practice. 3rd ed. Philadelphia: Wolters Kluwer; 2015.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839 42.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 2: Assessment of validity of items and tools to support application. CMAJ 2010;182:E472 8.

Yang C, Zhang Z, Zhang L, Tian J, Yu D, Wang J, et al. Quality assessment of clinical practice guidelines on tic disorders with AGREE II instrument. Psychiatry Res 2018;259:385 91.

Gavriilidis P, Roberts KJ, Askari A, Sutcliffe RP, Huo TL, Liu PH, et al. Evaluation of the current guidelines for resection of hepatocellular carcinoma using the appraisal of guidelines for research and evaluation II instrument. J Hepatol 2017;67:991 8.

Zhang ZW, Liu XW, Xu BC, Wang SY, Li L, Kang YY, et al. Analysis of quality of clinical practice guidelines for otorhinolaryngology in China. PLoS One 2013;8:e53566.

Grammatikopoulou MG, Theodoridis X, Gkiouras K, Stamouli EM, Mavrantoni ME, Dardavessis T, et al. AGREEing on guidelines for nutrition management of adult severe burn patients. J Parenter Enteral Nutr 2019;43:490-6.

Radwan M, Akbari Sari A, Rashidian A, Takian A, Abou Dagga S, Elsous A. Appraising the methodological quality of the clinical practice guideline for diabetes mellitus using the AGREE II instrument: A methodological evaluation. JRSM Open 2017;8:2054270416682673.

Gillespie BM, Bull C, Walker R, Lin F, Roberts S, Chaboyer W. Quality appraisal of clinical guidelines for surgical site infection prevention: A systematic review. PLoS One 2018;13:e0203354.

Messina C, Bignotti B, Bazzocchi A, Phan CM, Tagliafico A, Guglielmi G, et al. A critical appraisal of the quality of adult dual energy X ray absorptiometry guidelines in osteoporosis using the AGREE II tool: An EuroAIM initiative. Insights Imaging 2017;8:311 7.

Brasil RFG, Silva MJd, Moura ERF. Evaluation of the clinical protocol quality for family planning services of people living with HIV/AIDS. Rev Esc Enferm USP 2018;52:e03335.

Huang M, Zhou X. Appraisal of guidelines for androgenetic alopecia using the appraisal of guidelines for research and evaluation II instrument. J Eval Clin Pract 2015;21:1089 94.

Lucendo AJ, Arias Á, Redondo González O, Molina Infante J. Quality assessment of clinical practice guidelines for eosinophilic esophagitis using the AGREE II instrument. Expert Rev Gastroenterol Hepatol 2017;11:383 90.

Holmer HK, Ogden LA, Burda BU, Norris SL. Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLoS One 2013;8:e58625.

Tolunay O, Tolunay I, Yildizdaş RD, Celik T, Çelik Ü. Appraisal of the “pediatric ARDS: Consensus recommendations from the pediatric acute lung injury consensus conference” with the AGREE II instrument. Turk J Med Sci 2018;48:84 8.

Sekercioglu N, Al Khalifah R, Ewusie JE, Elias RM, Thabane L, Busse JW, et al. A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument. Int Urol Nephrol 2017;49:273 84.

Malanchini G, Stefanini GG. Another reason to endorse and spread guidelines. Eur Heart J 2019;40:82 3.

Kyriakoulis K, Patelarou A, Laliotis A, Wan AC, Matalliotakis M, Tsiou C, et al. Educational strategies for teaching evidence based practice to undergraduate health students: Systematic review. J Educ Eval Health Prof 2016;13:34.

Ruzafa Martínez M, López Iborra L, Barranco DA, Ramos Morcillo AJ. Effectiveness of an evidence based practice (EBP) course on the EBP competence of undergraduate nursing students: A quasi experimental study. Nurse Educ Today 2016;38:82 7.

Dahm P, Yeung LL, Chang SS, Cookson MS. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. J Urol 2008;180:451 60.

Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15:155 63.

Terrace L. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 2003;12:18 23.

Ou Y, Goldberg I, Migdal C, Lee PP. A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology 2011;118:1017 23.

Rashidian A, Yousefi Nooraie R. Development of a Farsi translation of the AGREE instrument, and the effects of group discussion on improving the reliability of the scores. J Eval Clin Pract 2012;18:676 81.

WOSCAN Cancer Nursing and Pharmacy Group. Chemotherapy extravasation guideline 2012. Available from:https://www.beatson. scot.nhs.uk/content/mediaassets/doc/Extravasation%20guidance.pdf.

Pan Birmingham Cancer Network Governance Committee. Guideline for the Management of Extravasation. NHS Pan Birmingham Cancer Network 2014. Available from: https://www. uhb.nhs.uk/Downloads/pdf/CancerPbExtravasation.pdf.

Pan Birmingham Cancer Network Governance Committee. Guideline for the management of extravasation of a cytotoxic agent or a monoclonal antibody used in the treatment of malignant disease. Worcestershire Acute Hospitals NHS Trust 2015. Available from: file:///C:/Users/aria/Downloads/WAHT-HAE-014%20v4.2%20(1).pdf.

West Midlands Expert Advisory Group for Systemic Anti cancer Therapy (SACT). Guidelines for the Management of Extravasation of a Systemic Anti Cancer Therapy Including Cytotoxic Agents 2017. Available from: https://www.england.nhs.uk/mids-east/wp-content/uploads/sites/7/2018/04/management-extravasation-of-a-systemic-anti-cancer-therapy-including-cytotoxic-agents.pdf.

Pan Birmingham Cancer Network Governance Committee. Clinical Guideline for the Management of Extravasation of Cytotoxic Drugs in Adults 2017. Available from: https:// docplayer.net/23907946-Clinical-guideline-for-the-management-of-extravasation-of-cytotoxic-drugs-in-adults-1-aim-purpose-of-this-guideline.html.

Norris SL, Burda BU, Holmer HK, Ogden LA, Fu R, Bero L, et al. Author’s specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol 2012;65:725 33.

Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: Cross sectional study. BMJ 2011;343:d5621.

Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R. Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse. PLoS One 2012;7:e47343.

Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN. Conflicts of Interest in Cardiovascular Clinical Practice Guidelines. JAMA Internal Medicine 2011;171:577-84.

Northern Ireland Cancer Network. Guidelines for the safe prescribing, handling and administration of Systemic Anti Cancer Therapies (SACT). NICaN Pharmacy group 2016. Available from: file:///C:/Users/aria/Downloads/Guidelines-for-the-safe-prescribing-handling-administration-of-hazardous.pdf.

London Cancer Alliance. London ICS Guidelines for the Safe Prescribing, Handling and Administration of Systemic Anti Cancer Treatment Drugs 2015. Available from: http://www. londoncancer.org/media/144228/Appendix20D_Pan-london-cytotoxic-handbook-july-2015.pdf.

Leung M, Bland R, Bladassarre F, Green E, Kaizer L, Hertz S, et al. Part 2: Administration of chemotherapy and management of preventable adverse events. Toronto (ON): Cancer Care Ontario; Program in Evidence-based Care Practice Guideline Report No.: 12-12-2; 2014.


Refbacks

  • There are currently no refbacks.